Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-En Lin

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Blood Research|June 2, 2026
Real-world experience with gilteritinib maintenance following allogeneic transplantation in relapsed/refractory AML patients harboring FLT3 mutationsYun-Tzu Lin, Xavier Cheng-Hong Tsai, Feng-Ming Tien, et al.
Clinical Epigenetics|April 6, 2018
Dynamics of <i>DNMT3A</i> mutation and prognostic relevance in patients with primary myelodysplastic syndromeMing-En Lin, Hsin-An Hou, Cheng-Hong Tsai, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 30, 2025
Molecular Milestones and Survival Outcomes of Ponatinib Treatment in Patients With Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: A Real-World AnalysisTai-Chung Tseng, Yu-Sung Chang, Xavier Cheng-Hong Tsai, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Blood Research|June 2, 2026
Real-world experience with gilteritinib maintenance following allogeneic transplantation in relapsed/refractory AML patients harboring FLT3 mutationsYun-Tzu Lin, Xavier Cheng-Hong Tsai, Feng-Ming Tien, et al.
Clinical Epigenetics|April 6, 2018
Dynamics of <i>DNMT3A</i> mutation and prognostic relevance in patients with primary myelodysplastic syndromeMing-En Lin, Hsin-An Hou, Cheng-Hong Tsai, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 30, 2025
Molecular Milestones and Survival Outcomes of Ponatinib Treatment in Patients With Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: A Real-World AnalysisTai-Chung Tseng, Yu-Sung Chang, Xavier Cheng-Hong Tsai, et al.
Pageof 3